Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tn Antigen Expression Contributes to an Immune Suppressive Microenvironment and Drives Tumor Growth in Colorectal Cancer
Lenneke A. M. Cornelissen, Athanasios Blanas, Anouk Zaal, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Altered glycosylation in cancer: A promising target for biomarkers and therapeutics
Divya Thomas, Ashok Kumar Rathinavel, Prakash Radhakrishnan
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188464-188464
Open Access | Times Cited: 237
The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong, Suideng Qin, Lunzhi Dai, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 166
Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Nora Berois, Álvaro Pittini, Eduardo Osinaga
Cancers (2022) Vol. 14, Iss. 3, pp. 645-645
Open Access | Times Cited: 72
Targeting the Siglec–Sialic Acid Immune Axis in Cancer: Current and Future Approaches
Heinz Läubli, Sam C. Nalle, Daniel Maslyar
Cancer Immunology Research (2022) Vol. 10, Iss. 12, pp. 1423-1432
Open Access | Times Cited: 52
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth
Emma Scott, Kirsty Hodgson, Beatriz de la Calle, et al.
Oncogene (2023) Vol. 42, Iss. 12, pp. 926-937
Open Access | Times Cited: 35
Mapping of truncated O-glycans in cancers of epithelial and non-epithelial origin
Troels Boldt Rømer, Mikkel Koed Møller Aasted, Sally Dabelsteen, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 9, pp. 1239-1250
Open Access | Times Cited: 44
Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors
Yasuyuki Matsumoto, Tongzhong Ju
Cancers (2023) Vol. 15, Iss. 14, pp. 3536-3536
Open Access | Times Cited: 18
The transcriptional landscape of glycosylation-related genes in cancer
Ernesto Rodríguez, Dimitri Lindijer, Sandra J. van Vliet, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109037-109037
Open Access | Times Cited: 7
The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2)
Valeria da Costa, Sandra J. van Vliet, Paula Carasi, et al.
Cancer Letters (2021) Vol. 518, pp. 72-81
Closed Access | Times Cited: 34
A Sweet Warning: Mucin-Type O-Glycans in Cancer
Yuhan Zhang, Lingbo Sun, Changda Lei, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3666-3666
Open Access | Times Cited: 25
A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy
Rui Freitas, Andréia Miranda, Dylan Ferreira, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 540-556
Closed Access | Times Cited: 4
Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression
Hong Tian, Jiali Yu, Xiaoli Chu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers
Christabelle Rajesh, Prakash Radhakrishnan
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 12
Tumor glucose metabolism and the T cell glycocalyx: implication for T cell function
Fabian Schuurmans, Kyra E. Wagemans, Gosse J. Adema, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications
Xinqing Zhu, Abdullah Al-Danakh, Lin Zhang, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2598-2598
Open Access | Times Cited: 16
Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of Fucosylation
Gabriele Antonarelli, Valentina Pieri, Francesca Porta, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 840-840
Open Access | Times Cited: 10
Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated Proteins
Mikkel Koed Møller Aasted, Aaron C. Groen, John T. Keane, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 10, pp. 1204-1214
Open Access | Times Cited: 10
FUT9-Driven Programming of Colon Cancer Cells towards a Stem Cell-Like State
Athanasios Blanas, Anouk Zaal, Irene van der Haar Àvila, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2580-2580
Open Access | Times Cited: 21
Glycosylation in Cervical Cancer: New Insights and Clinical Implications
Zhiwei Xu, Yaqin Zhang, Dickson Kofi Wiredu Ocansey, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 19
The tumor-associated Tn antigen fosters lung metastasis and recruitment of regulatory T cells in triple negative breast cancer
María Florencia Festari, Valeria da Costa, Santiago A. Rodríguez-Zraquia, et al.
Glycobiology (2021) Vol. 32, Iss. 5, pp. 366-379
Open Access | Times Cited: 19
Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer
Yiyi Li, Xinyu Wang, Yan Li, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 777-791
Closed Access | Times Cited: 7
The pleiotropic CLEC10A: implications for harnessing this receptor in the tumor microenvironment
Nadia L. van der Meijs, Maria Alejandra Travecedo, Filipa Marcelo, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 7, pp. 601-612
Open Access | Times Cited: 2
Expression and Impact of C1GalT1 in Cancer Development and Progression
Yangu Wan, Lu‐Gang Yu
Cancers (2021) Vol. 13, Iss. 24, pp. 6305-6305
Open Access | Times Cited: 16
Mapping the O-GlcNAc Modified Proteome: Applications for Health and Disease
Rajan A. Burt, Ibtihal Alghusen, Sophiya John Ephrame, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 11
Targeting Tn-positive tumors with an afucosylated recombinant anti-Tn IgG
Yasuyuki Matsumoto, Nan Jia, Jamie Heimburg‐Molinaro, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top